Maxim Sharakin

Personal profile

Projects

• Health Technology Assessment: Medicines for Dementia due to Alzheimer's and Parkinson's Disease / Team member / Project completed
• Health Technology Assessment: Infliximab reference product versus biosimilar for the treatment of rheumatoid arthritis / Team member / Project completed

Publications

• Mattli, R.; Tomonaga, Y.; Tzogiou, C.; Vinci, L.; Sharakin, M.; Wirth, B.; Carlander, M.; Schliek, M.; Egli, Ph.; Gerber-Grote, A.; Nordström, K.; Wieser, S.,

  2022.

  Health technology assessment (HTA) : medicines for dementia due to Alzheimer's and Parkinson's disease.

  Bern:

  Bundesamt für Gesundheit BAG.

  Available from: https://www.bag.admin.ch/bag/de/home/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/hta/hta-projekte/medikamentebeialzheimerdemenz.html

• Mattli, Renato; Grobet, Cécile; Sharakin, Maxim; Pöhlmann, Johannes; Vinci, Linda; Syleouni, Maria-Eleni; Carlander, Maria; Meier, Flurina; Egli, Philipp; Gerber-Grote, Andreas; Wieser, Simon,

  2022.

  Infliximab reference product versus biosimilar for the treatment of rheumatoid arthritis.

  Bern:

  Bundesamt für Gesundheit BAG.

  Available from: https://www.bag.admin.ch/bag/en/home/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/hta/hta-projekte/infliximab.html

• Sharakin, Maxim,

  2021.

  Alles ist Wissen, Wissen ist alles.

  Gesundheitsökonomie @ ZHAW.

  Available from: https://blog.zhaw.ch/gesundheitsoekonomie/2021/10/28/alles-ist-wissen-wissen-ist-alles/

go back